MedTrace Logo

The Relaxation and Blood Pressure in Pregnancy (REBIP) Study

NCT00303173 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2008-06-25

No results posted yet for this study

Summary

Over 10% of women have high blood pressure during their pregnancy which may affect their health or that of their baby. There are currently no methods to prevent most high blood pressure in pregnancy and some treatments are not desirable for use in pregnancy. Previous research indicates that simple relaxation methods can reduce blood pressure and anxiety levels for some people, but this has not been well-studied, especially during pregnancy. This pilot study is intended to determine how guided imagery (imagining relaxing scenes) affects blood pressure and anxiety, and to assess how satisfied women are with this technique. Sixty-six pregnant women with high blood pressure will be randomly assigned to (1) listen to a guided imagery audio-compact disc or (2) quiet rest, at least twice-daily for 4 weeks. All women in both groups will receive all usual care, plus will have their blood pressure measured regularly during 1 day per week for 4 weeks. This study will determine if imagery lowers maternal blood pressure, and if further research on imagery effects on pregnancy health outcomes is feasible.

Conditions

  • Hypertension
  • Hypertension, Pregnancy-Induced
  • Pre-Eclampsia

Interventions

BEHAVIORAL

Guided Imagery

Sponsors & Collaborators

  • Dalhousie University

    collaborator OTHER

  • AWHONN Canada, with Canadian Nurses Foundation Nursing Care Partnership

    collaborator UNKNOWN

  • IWK Health Centre with Canadian Nurses Foundation Nursing Care Partnership

    collaborator UNKNOWN

  • University of Toronto

    lead OTHER

Principal Investigators

  • C. Faith Wight Moffatt, MS, PhD (c) · University of Toronto, Dalhousie University

  • Ellen Hodnett, PhD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2006-12-31
Completion
2007-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00303173 on ClinicalTrials.gov